MACROH2A1 and neoplasm: Scientific evidences support a tumor suppressive role for macroH2A1.1 and macroH2A2 (10, 22, 23, 35, 37–39), while macroH2A1.2 is an oncogene associated with tumor progression and negative patient outcome (5, 10).